![Headshot portrait of Electron Kebebew - Harry A. Oberhelman, Jr. and Mark L. Welton Professor](https://biox.stanford.edu/files/styles/profile_thumbnail/public/kebebew.webp?orig=png)
Bio-X Affiliated Faculty
Dr. Kebebew’s translational and clinical investigations have three main scientific goals:
- to develop effective therapies for fatal, rare and neglected endocrine cancers,
- to identify new methods, strategies and technologies for improving the diagnosis and treatment of endocrine neoplasms and the prognostication of endocrine cancers, and
- to develop methods for precision treatment of endocrine tumors.